Table 2.
Prevalence Ratios (95% CI) for Activity Limitations Among US Adults 50 to 64 Years Old with Versus Without Individual Chronic Conditions
| Chronic condition | Functional limitations | Mobility limitations | BADL difficulty | IADL difficulty |
|---|---|---|---|---|
| Prevalence ratio (95% CI) - model 1 | ||||
| Hypertension | 1.34 (1.17–1.53) | 1.48 (1.20–1.81) | 1.65 (1.30–2.09) | 1.51 (1.21–1.87) |
| High cholesterol | 1.25 (1.10–1.42) | 1.39 (1.04–1.85) | 1.55 (1.30–1.85) | 1.35 (1.13–1.60) |
| Diabetes mellitus | 1.48 (1.33–1.66) | 1.72 (1.35–2.20) | 1.82 (1.50–2.22) | 1.91 (1.55–2.35) |
| Obesity | 1.67 (1.43–1.94) | 2.00 (1.56–2.57) | 1.83 (1.43–2.35) | 1.75 (1.36–2.26) |
| CKD | 1.47 (1.28–1.67) | 1.72 (1.25–2.36) | 1.76 (1.49–2.08) | 1.63 (1.32–2.02) |
| Cancer | 1.11 (0.96–1.29) | 1.35 (1.05–1.75) | 1.31 (0.98–1.76) | 1.40 (1.10–1.78) |
| Stroke | 1.98 (1.69–2.33) | 2.03 (1.27–3.26) | 3.07 (2.48–3.81) | 2.69 (2.04–3.55) |
| Coronary heart disease | 1.95 (1.70–2.25) | 2.01 (1.38–2.94) | 2.36 (1.78–3.12) | 2.33 (1.77–3.07) |
| Heart failure | 2.22 (1.97–2.50) | 2.92 (1.92–4.42) | 3.31 (2.40–4.58) | 3.07 (2.35–4.00) |
| COPD/asthma | 1.63 (1.45–1.83) | 2.27 (1.84–2.80) | 2.40 (2.00–2.87) | 2.46 (2.01–3.02) |
| Arthritis | 2.72 (2.33–3.18) | 3.19 (2.32–4.39) | 4.46 (3.36–5.92) | 3.52 (2.69–4.59) |
| Depression | 2.08 (1.81–2.39) | 2.05 (1.36–3.10) | 3.02 (2.60–3.50) | 2.86 (2.42–3.39) |
| Prevalence ratio (95% CI) - model 2 | ||||
| Hypertension | 1.31 (1.15–1.49) | 1.42 (1.16–1.73) | 1.58 (1.25–2.01) | 1.45 (1.17–1.81) |
| High cholesterol | 1.26 (1.11–1.42) | 1.39 (1.05–1.85) | 1.56 (1.32–1.85) | 1.36 (1.15–1.60) |
| Diabetes mellitus | 1.47 (1.33–1.64) | 1.71 (1.35–2.16) | 1.81 (1.50–2.19) | 1.90 (1.55–2.33) |
| Obesity | 1.76 (1.51–2.04) | 2.15 (1.72–2.68) | 1.99 (1.56–2.53) | 1.89 (1.48–2.41) |
| CKD | 1.40 (1.24–1.59) | 1.61 (1.16–2.24) | 1.64 (1.40–1.91) | 1.53 (1.24–1.87) |
| Cancer | 1.12 (0.96–1.30) | 1.37 (1.05–1.78) | 1.32 (0.99–1.76) | 1.40 (1.11–1.76) |
| Stroke | 1.73 (1.49–2.01) | 1.63 (1.01–2.62) | 2.51 (1.95–3.23) | 2.21 (1.66–2.95) |
| Coronary heart disease | 1.71 (1.49–1.97) | 1.64 (1.06–2.54) | 1.95 (1.45–2.60) | 1.93 (1.46–2.53) |
| Heart failure | 2.04 (1.78–2.33) | 2.52 (1.54–4.14) | 2.94 (1.97–4.40) | 2.74 (1.97–3.81) |
| COPD/asthma | 1.52 (1.34–1.71) | 2.06 (1.67–2.53) | 2.17 (1.83–2.58) | 2.24 (1.82–2.75) |
| Arthritis | 2.62 (2.24–3.07) | 2.99 (2.17–4.12) | 4.21 (3.17–5.59) | 3.31 (2.53–4.34) |
| Depression | 1.99 (1.76–2.25) | 1.93 (1.29–2.88) | 2.81 (2.42–3.25) | 2.68 (2.25–3.18) |
| Prevalence ratio (95% CI) - model 3 | ||||
| Hypertension | 1.02 (0.90–1.15) | 1.04 (0.85–1.26) | 1.12 (0.90–1.38) | 1.07 (0.85–1.34) |
| High cholesterol | 1.00 (0.87–1.14) | 1.07 (0.82–1.41) | 1.10 (0.90–1.36) | 0.97 (0.81–1.16) |
| Diabetes mellitus | 1.10 (0.98–1.23) | 1.18 (0.90–1.55) | 1.24 (1.02–1.50) | 1.39 (1.16–1.68) |
| Obesity | 1.40 (1.19–1.65) | 1.68 (1.35–2.09) | 1.37 (1.05–1.81) | 1.30 (1.00–1.70) |
| CKD | 1.20 (1.05–1.38) | 1.27 (0.89–1.80) | 1.27 (1.05–1.54) | 1.21 (0.96–1.52) |
| Cancer | 0.96 (0.82–1.13) | 1.16 (0.86–1.56) | 1.11 (0.87–1.43) | 1.19 (0.94–1.49) |
| Stroke | 1.30 (1.10–1.54) | 1.20 (0.76–1.87) | 1.62 (1.19–2.20) | 1.38 (1.04–1.84) |
| Coronary heart disease | 1.15 (0.94–1.40) | 0.98 (0.64–1.51) | 0.94 (0.60–1.47) | 1.07 (0.74–1.55) |
| Heart failure | 1.21 (1.01–1.44) | 1.37 (0.79–2.39) | 1.58 (0.94–2.65) | 1.41 (0.90–2.23) |
| COPD/Asthma | 1.16 (1.02–1.31) | 1.57 (1.20–2.07) | 1.48 (1.19–1.85) | 1.58 (1.27–1.97) |
| Arthritis | 2.21 (1.86–2.63) | 2.32 (1.58–3.38) | 3.13 (2.28–4.28) | 2.56 (1.89–3.48) |
| Depression | 1.51 (1.37–1.67) | 1.37 (0.97–1.93) | 1.91 (1.58–2.32) | 1.87 (1.50–2.32) |
BADLs, basic activities of daily living; IADLs, instrumental activities of daily living; CI, confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease
Model 1: adjusted for age, sex, and race/ethnicity
Model 2: adjusted for age, sex, race/ethnicity, education, and cigarette smoking
Model 3: adjusted for age, sex, race/ethnicity, education, and cigarette smoking and the other chronic conditions listed in the table
Italics indicates statistical significance (P<0.05)